BOTHELL, Wash., March 23, 2017 /PRNewswire/ -- Mirabilis Medical, a Seattle-area developer of advanced medical technology for non-invasive surgery, announced today CE Mark authorization for marketing of the Mirabilis System for treatment of uterine fibroids throughout the European Union. ...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]broid-treatment-300428867.html